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ABSTRACT 
FUNCTIONAL CHARACTERIZATION OF LOC115098: A NOVEL GENE 
CONSERVED IN EUKARYOTIC GENOMES 
 
Esra Karaköse 
M.Sc. in Molecular Biology and Genetics 
Supervisor: Assist Prof. Uygar H. Tazebay 
January 2007, 76 Pages 
 
Loc115098 is a newly identified gene in our laboratory. The gene was firstly 
discovered in an unrelated study in which the cis-acting regulatory elements of a 
neighboring gene NIS (Sodium-Iodide Symporter) were investigated. It is composed 
of 4 exons. According to the computational predictions, it has rather interesting 
features such as having a composition of mostly charged amino acids, carrying a 
nuclear localization signal and being well conserved throughout the eukaryotic 
kingdom. Our aim in this study was to understand the function of this new gene. 
Firstly we confirmed that it is expressed in several different tissues, later we 
conducted a subcellular localization study whose results led us to hypothesize that 
the function of loc115098 could be related to cell cycle regulation. According to our 
hypothesis we decided to utilize a lower eukaryote carrying a human homologue of 
loc115098 which we selected to be Aspergillus nidulans. It was a very useful model 
organism for our study not only because it carries a very similar homologue of 
loc115098 but also it is an easily handled organism which is widely used for genetic 
studies. Firstly we compared the expression profile of loc115098 in several cell cycle 
mutants of A. nidulans as well as a wild type strain, the results indicated that the 
expression of loc115098 decreases in the restrictive temperature of cell cycle mutant 
strains. We also conducted subcellular localization studies in A. nidulans and the 
results indicated that it was mostly cytoplasmic and sometimes perinuclear. Our 
other aim was to utilize A. nidulans as a model for our knock-out experiments. We 
designed a knock-out system by the help of a sophisticated method called Double-
Joint PCR. Our first attempts supported that the knock-out of loc115098 was likely 
to cause lethality in the organism and therefore we improved our system to 
conditionally knock out the gene. Our preliminary results indicated that the knock 
out of loc115098 causes cell death and we suspect that it could be due to a damage in 
one of the crucial metabolic events for cell viability such as mitosis. Our attempts to 
functionally characterize the function of loc115098 are currently going on. 
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ÖZET 
ÖKARYOTİK CANLILARDA KORUNMUŞ OLAN LOC115098 GENİNİN 
İŞLEVSEL TANIMLANDIRILMASI 
 
Esra Karaköse 
Moleküler Biyoloji ve Genetik Yüksek Lisans Derecesi 
Tez Yöneticisi: Yard. Doç. Dr. Uygar H. Tazebay 
Ocak 2007, 76 Sayfa 
 
 
 
Loc115098 ilk kez tarafımızdan bulunmuş bir gendir. İlk defa bu genin komşusu olan 
NIS (Sodyum-Iyot Simporter) geninin anlatımından sorumlu cis kontrol bölgelerinin 
aydınlatılması amacıyla yapılan bir çalışma sırasında bulunmuştur. Bu gen 4 
eksondan meydana gelmektedir.  Bioınformatik analizlerden faydalanarak yaptığımız 
araştırmalar bu genin oldukça ilginç özelliklere sahip olduğunu gösterdi, örneğin 
proteinin yapısı genel olarak pozitif yüklü amino asitlerden oluşuyor, çekirdek 
sinyali taşıyor ve ökaryotik organizmalarda oldukça korunmuş bir şekilde bulunuyor. 
Bizim bu çalışmadaki amacımız bu genin işlevini anlamaktı. Bu nedenle öncelikle 
farklı dokularda bu genin ifadesi olduğunu teyid ettik. Sonra bu proteinin hücre 
içersindeki konumunu anlamak için çalışmalar yaptık. Sonuçlar, bu proteinin hücre 
döngüsü kontrolüyle ilgili bir işleve sahip olabileceği hipotezini kurmamızı sağladı. 
Bunun üzerine çalışmalarımızı sürdürmek amacıyla loc115098 geninin homoloğunu 
taşıyan daha düşük bir ökaryot olan Aspergillus nidulans’ı seçtik. Bu organizma 
bizim çalışmalarımız açısından oldukça kullanışlıydı çünkü hem loc115098 geninin 
çok benzer bir homoloğunu taşıyordu hem de bir model organizma olarak genetik 
araştırmalarda sıklıkla kullanılıyordu. Öncelikle loc115098 geninin anlatımını çeşitli 
hücre döngüsü mutasyonlarına sahip olan A. nidulans ırklarında ve doğal (wild type) 
ırkta karşılaştırmalı olarak inceledik. Bu çalışmanın sonucu bize mutant olan ırkların 
yaşamalarına müsaade etmeyen sıcaklık derecelerinde loc115098 ifadesinin 
azaldığını gösterdi. Aynı zamanda bu organizma ile de LOC115098 proteinin hücre 
içindeki konumlanışını araştırdık ve sonuç bize bu proteinin çoğunlukla sitoplazmada 
bazen de çekirdeğin etrafını saracak şekilde bulunduğunu gösterdi. Ayrıca Double-
Joint PCR adı verilen oldukça sofistike bir metoddan faydalanarak knock-out 
çalışmalar yaptık ve ilk elde ettiğimiz sonuçlar bize bu genin, hücrenin yaşamsal 
olaylarından sorumlu bir işleve sahip olabileceğini gösterdi çünkü bu genin knock-
out edildiği durumlarda canlının yaşadığı örneklere hiç rastlamadık. Loc115098 
geninin işlevini aydınlatmaya dair çalışmalarımız halen devam ediyor.
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All truths are easy to understand once they are discovered; 
the point is to discover them. 
  
Galileo Galilei 
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1. INTRODUCTION 
1.1. General knowledge about Hypothetical Proteins 
The completion of Human Genome Project (Human Genome Sequencing 
Consortium, 2004), revealed that the expected number of genes in the human 
genome is neither around 100000 as it was expected in some text books nor around 
30000 (Lander et al., 2001) as expected in others. More recent studies have indicated 
that this number varies between 20000 and 25000. Even though we are able to 
perform such estimations we are still far from understanding the human genome in 
its all aspects. Indeed it is well-known that coding sequences, as well as many non-
coding regulatory regions tend to keep their sequences conserved during evolution. 
Although there are certain efforts to understand the function of non-coding 
regulatory conserved elements at the level of entire genome, the identification, 
functional annotation and systemic classification of the coding sequences remain 
incomplete.  
Until today the DNA sequences of more than 100 species have been completed and 
one of the most surprising outcomes of genome research is that roughly 20-40% of 
genes in newly sequenced genomes do not have statistically significant matches to 
functionally annotated sequences and they are annotated as ‘hypothetical proteins’ 
(Eisenstein et al., 2000).  
We believe that one of the most important questions of the today’s genome research 
is to assign annotations to the genes whose biological function is yet to be 
understood. The most common approaches and several methods will be mentioned in 
the following sections. 
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1.2. How to Study the Hypothetical Proteins 
Since the annotation of hypothetical proteins encoding genes is crucial for the future 
of genomic studies, the tools which are generated for this scope is a hot topic in the 
field, too. There are indeed several different approaches to study the hypothetical 
proteins and it is possible to classify them as ‘the bioinformatics tools’ and ‘the 
biochemical and genomic tools’.  
1.2.1. The bioinformatics tools  
There are several different approaches to functionally identify new genes. However 
the most accurate and effective annotations which have been performed up to date 
are based on sequence homology. Among them BLAST and PSI-BLAST are the 
most widely used tools (Altschul et al., 1997). However more advanced tools which 
have been used by several groups exist and the number of these tools keep growing 
everyday. Some of these methods will be named here. One of the most reliable tools 
is ‘The Rosetta Stone Technique’ which is based on protein-domain fusion events 
(Marcotte et al., 1999) (Enright and Spratt, 1999). There are others which are based 
on chromosomal proximity information. The rational behind this technique is that 
when two genes appear as a neighboring gene pair in the genomes of several 
distantly related organisms, meaning that they form a conserved gene cluster. This 
suggests the possibility that these genes might be functionally related (Overbeek et 
al., 1999). Another technique is based on the phylogenetic profile method. Basically 
this method indicates the presence or the absence of the gene of interest in each 
organism by an entry of 1 or 0. Thus the functional linkage is established when the 
two genes have similar phylogenetic profiles, they show a correlated pattern of 
inheritance across the genomes examined (Marcotte, 2000). Some other methods also 
combine the ones mentioned above (Zheng et al., 2002) in which they explain the 
genomic functional annotation using co-evolution profiles of gene clusters. Finally, 
by using specific amino acid frequency and the periodicity at the proteome level, 
functionally unknown proteins can be characterized (Fujishima et al., 2003).  
Among all these methods, we used the most efficient and established one for our 
  
3 
bioinformatics analyses; BLAST. Moreover, we also focused on the biochemical and 
genomic analyses of our gene of interest. 
1.2.2. Biochemical and genomic approaches to study hypothetical proteins 
Although there is no certain method to follow in order to conduct biochemical and 
genomic studies of the hypothetical proteins, the general forward and reverse 
genetics methods are applicable. Firstly the confirmation of the expression of these 
genes is essential. After this confirmation, further analyses can be performed 
depending on the future scope of the study. The overexpression and disruption of the 
gene of interest are two main approaches in order to observe how crucial the protein 
is for the organism. As long as there is no domain similarity with previously 
annotated proteins, any method aiming to identify the protein-protein interaction 
such as immunoprecipitation or yeast two hybrid methods would be useful to find the 
targets of the hypothetical proteins. Moreover some localization studies by using 
immunofluorescence can be conducted to observe the subcellular localization of the 
hypothetical proteins. All these experiments can also be performed in time or growth 
dependent manners meaning that different developmental stages of a given organism 
could be investigated in terms of gene expression or the localization studies can be 
performed in a time dependent manner and the difference can be observed. Moreover 
the interaction of the protein of interest with other proteins may also vary according 
to the developmental or metabolic activities. 
On the other hand the disruption of the gene of interest could also be a prominent 
approach. In case of any phenotypic changes or lethality occurs this would bring new 
insights to the study. Moreover, according to the bioinformatics analyses, some 
mutations can be inserted to check the possible outcomes of the mutation of those 
sequences.  
Other more sophisticated approaches such as crystallizing the protein and exploring 
the 3D structure are possible. However these methods are generally considered to be 
more complicated and require higher technology and longer periods of commitment.  
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1.3 General Knowledge about ‘Loc115098’ 
1.3.1. Identification of loc115098 as an expressed gene 
Loc115098 was firstly identified in an unrelated study where cis-acting 
transcriptional elements of the NIS (Sodium-Iodide Symporter) gene were being 
analyzed. The focus of that study was to analyze a putative transcriptional control 
element localized in the 3’ downstream of NIS gene by using a tool called VISTA 
(Negre et al., 2005). In this study 10 conserved putative regions were identified and 
we firstly discovered the 5’ regulatory region of Loc115098 as one of these putative 
regions and then the Loc115098 itself was discovered by our group (Hani Alotaibi et 
al, unpublished data). The gene could be found in University of California Santa 
Cruz database (Kent et al., 2002) with the accession number of LOC115098. 
1.4. Model Organisms to Study Gene Function 
Model systems have always been useful in basic research. They have contributed to 
the creation and development of basic biological knowledge for many years. 
Especially in the last decades due to the rapidly expanding genetic research area 
revealing the genomes of different species, model organisms have gained even more 
importance. The common evolutionary heritage makes it possible to use genetically 
tractable organisms to model important aspects of human medical disorders such as 
cancer, birth defects, neurological dysfunctions, reproductive failure, malnutrition 
and aging in systems amenable to rapid and powerful experimentation (Spradling et 
al., 2006).  
Utilizing model organisms will help us identify common genes, proteins and 
biological processes. This will not only be useful for unrevealing the complications 
of human genetic disorders but also establish a better understanding of the roles of 
the common mechanisms which take part in all fundamental life processes, including 
development, physiology, growth, behavior and aging. Moreover the studies with 
model organisms provide information which can not practically be obtained in any 
other way. Mostly due to practical difficulties to utilize and manipulate higher 
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organisms and sometimes due to the ethical issues, the idea of using a model system 
has always been very useful. 
1.4.1. General Knowledge about Model Organisms 
The number of model organisms which are used for genetic, biochemical and 
molecular studies are growing rapidly. The most commonly used organisms include 
rat (Rattus norvegicus), mouse (Mus musculus), zebrafish (Danio rerio), the fruit fly 
(Drosophila melanogaster), the budding yeast Saccharomyces cerevisiae, the 
amphibian Xenopus tropicalis, the nematode Caenorhabditis elegans, cellular slime 
mold Dictyostelium discoideum and finally the ascomycete Aspergillus nidulans. 
They are all useful to study different functions, for instance the C. elegans is mostly 
utilized for neurobiological and developmental studies whereas the S. cerevisiae is a 
good model to study the control of cell division. According to the aim of the study 
and the laboratory facilities, the most easily handled and the most appropriate 
organism can be selected from a big variety.   
Taking fungi into consideration, it is obvious that they have a lot of features which 
make them useful as experimental genetic organism. Many of the fungi that are 
commonly used for genetic studies have most or all of the following features: 
• A haploid phase for mutagenesis and screening. 
• A dikaryon or heterokaryon phase for complementation and epistasis analysis. 
• The ability to grow on defined media for selection and screening of nutritional and 
drug-resistance markers. 
• The ability to grow at wide temperature ranges which facilitates the isolation of 
conditional lethal mutants. 
• Heterothallic strains for out-crossing. 
• Homothallic derivatives to allow haploid screens for mutants that are defective in 
fundamentally diploid processes (for example, meiosis). 
• Small genomes (12–50 Mb) to facilitate mutant recovery and gene cloning. 
• The ability to carry out tetrad analysis, in which all four meiotic products are held 
together in an ascus. (Casselton and Zolan, 2002)  
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1.4.2. Features and Characteristics of Aspergillus nidulans 
Aspergillus nidulans is an ascomycetes belonging to the subphylum of 
Euascomycetes (Ascomycota). However the filamentous ascomycota is called 
pyrenomycetes. The classification can be made as following according to Micheli ex 
Link, 1809:  
Kingdom: Fungi 
Phylum: Ascomycota 
Order: Eurotiales 
Family: Trichocomaceae 
Genus: Aspergillus 
Species: nidulans 
The yeasts which are unicellular ascomycotan fungi are considered to be the best 
organisms for the study of basic eukaryotic genetics (Hedges, 2002). The 
multicellular (filamentous) ascomycotan fungi have apparently larger genomes but 
they are as useful and practical to study basic eukaryotic genetics.  
Aspergillus nidulans first appeared in the literature as an alternative model to 
Neurospora crassa. It was firstly introduced by Guido Pontecorvo in the 1950s 
(PONTECORVO et al., 1953). Like all other ascomycetes, A. nidulans also has a sac 
formation which is called ascus. The nuclear fusion and meiosis take place in the 
ascus. This eventually leads to the formation of sexual spores so called ascospores. 
The ascospores are formed within the ascus by an enveloping membrane system, 
which packages each nucleus with its adjacent cytoplasm and provides the site for 
ascospore wall formation. These membranes are derived from the ascus plasma 
membrane. This larger structure bursts and releases the thick-walled haploid 
ascospores which are resistant to adverse environments, but when they come across 
to the right conditions they start germinating and form the new haploid fungus. The 
hyphea is one filament of A. nidulans carrying several nuclei. 
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Figure1.1. The pictures of A. nidulans which were taken by SEM (Scanning Electron 
microscope). Both pictures show how A. nidulans look like in its natural 
environment. 
    
Figure1.2. Different cultures of Aspergillus nidulans. Both pictures show how A. 
nidulans grows under laboratory conditions. It might have different color mutants as 
it is indicated in one of the pictures 
   
Figure1.3. In the first picture the conidial heads which are short and columnar are 
shown. Conidiophores are usually short, brownish and smooth-walled.  
Conidia are globose and rough-walled. In the second picture the cleistothecium of A. 
nidulans is shown pointing numerous reddish-brown ascospores. 
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1.4.2.1. Life Cycle of Aspergillus nidulans 
The life cycle of the fungal mycelium of A. nidulans consists of sexual and asexual 
cycles. A. nidulans is a web of branched filaments (hyphae) of connected 
compartments or cells, each containing several nuclei. This mycelium, or 
homokaryon, which develops from a single haploid spore, differentiates into many 
identical asexual spores known as conidia or conidiospores (the asexual cycle). A. 
nidulans is homothallic, which means that it is self fertile, but crosses can be initiated 
by hyphal fusions between homokaryons with genetically different nuclei. The 
resulting heterokaryons are not stable, but can be forced to maintain a balanced ratio 
of the component nuclei by including complementing auxotrophic mutations in the 
parental nuclei and forcing growth without the corresponding supplements. A. 
nidulans can also reproduce sexually. In the fruiting body, which produces the sexual 
spores, a pair of nuclei that is destined for meiosis divides in synchrony to form a 
mass of cells known as the ascogenous hypha. These hyphae are highly branched and 
each tip cell becomes an ascus (a specialized cell) in which the two haploid nuclei 
fuse. The diploid nucleus undergoes meiosis followed by a post-meiotic mitosis, 
which results in the formation of eight haploid ascospores. The fruiting body, called 
the cleistothecium, can hold tens of thousands of ascospores, which are released into 
the environment when the cleistothecium bursts open. In addition to an asexual cycle 
and sexual cycle, a parasexual cycle offers the genetic benefits of meiosis achieved 
through a mitotic route (PONTECORVO and KAFER, 1958). The parasexual cycle 
is initiated when haploid nuclei fuse in the vegetative cells of a heterokaryon and 
continue to divide mitotically. Crossing over might occur between homologues and 
random chromosome loss restores the haploid chromosome number, which is eight in 
A. nidulans. These events can be used to map gene orders and assign new genes to 
the eight linkage groups. (See Figure 1.4) 
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Figure1.4. The life cycle of A. nidulans shown schematically. The sexual cycle is 
shown in purple, the asexual cycle in orange and the parasexual cycle in green. 
(Casselton and Zolan, 2002)  
1.4.2.2. Cell cycle Mutant Strains of Aspergillus nidulans 
The A. nidulans cell cycle mutants have long been a good model to study gene 
function. The first mitotic mutants were screened by Ron Morris in 1975. He carried 
out the classical microscopic screen in which the morphology of the germinating 
conidiospore was used as the identifying phenotype. As the conidiospore germinates, 
the germ tube elongates to generate the first hyphal compartment, into which the 
conidiospore’s nucleus moves and divides. The mitosis mutants were those in which 
the nuclear division (but not cell elongation) was affected at the restrictive 
temperature. In this screen the idea was to isolate the mutants as temperature-
sensitive conditional-lethals because otherwise the cells which cannot go through 
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mitosis would immediately die. The permissive temperature was 32ºC and the 
restrictive temperature was 42ºC. Basically 3 classes of mutants were isolated in this 
study: nim (never in mitosis), bim (blocked in mitosis), nud (nuclear distribution). 
(See Figure 1.5) 
  
Figure1.5. The schematic representation of cell cycle mutants and how they were 
obtaine. The permissive temperature is 32ºC and the restrictive temperature is 42ºC. 
(Casselton and Zolan, 2002) 
The mutant strains we use in this study are nim, bim and sud mutants. The NimA 
protein is a kinase that controls the entry into mitosis (Osmani et al., 1987). Thus the 
nimA mutants are arrested in late in G2 with duplicated spindle pole bodies, the 
fungal equivalent of the centrosome (Oakley et al., 1983). Further genetic analyses 
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showed that the interphase arrest of nimA5 mutants was bypassed by bimE7 
mutation, with double mutants entering an aberrant mitotic state characterized by 
abnormalities of the nuclear envelope, which remains intact during mitosis in fungi, 
and the failure to form bipolar spindle (Osmani et al., 1991). In other words the 
bimE7 mutation causes nuclei to accumulate and persist in a pre-anaphase mitotic 
state with tightly condensed chromatin and a normal-appearing spindle apparatus at 
restrictive temperature(James et al., 1995). (See Figure 1.6) 
 
Figure1.6. The nimA5 and the bimE7 are shown in the picture. In the nimA5 mutant 
the cell cycle arrest occurs at late G2 whereas in the bimE7 mutant mid-mitotic arrest 
occurs. (O'Connell et al., 2003) 
The sud mutant has also the background of bimD6 mutation. The protein which is 
encoded by bimD shares sequence motifs with known DNA binding transcription 
factors (May et al., 1992a). The bimD6 mutant germlings at restrictive temperature 
block in anaphase and eventually undergo nuclear fragmentation. In other words the 
bimD6 mutation confers a heat-sensitive mitotic defect characterized by a failure of 
chromosomes to correctly attach to the spindle microtubules, resulting in an increase 
in chromosome loss. The extragenic suppressors of bimD6 (sud) were isolated and 
characterized before (Holt and May, 1996b). Moreover it was discovered that in 
addition to their ability to suppress bimD6, sud genes are themselves required for 
successful nuclear division in A.nidulans.  The germlings harboring sud mutations 
with the bimD6 mutation undergo normal rounds of interphase and mitosis at 37ºC. 
After a shift to 25ºC for 8 hours, the approximate length of one cell cycle, nuclear 
morphology of all sud strains strikingly alters. The nuclei are not seen as delimited 
organelles but stretch about the hyphal interior as disorganized masses of chromatin. 
(Holt and May, 1996a). 
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1.4.3. Why we selected Aspergillus nidulans 
There were several reasons which led us to choose the Aspergillus nidulans as our 
experimental model. First of all, the homologues counterpart of loc115098 in the 
Aspergillus genome had 34.4% identity with the human homologue. (From now on 
the Aspergillus homologue will be called AN0879.3.) This high conservation rate 
would make our results more reliable. Furthermore Aspergillus nidulans is a non 
pathogenic and easily handled model organism for genetic, molecular and 
biochemical studies. It grows on very cheap and simple growth media. 
Saccharomyces cerevisiae could have been another alternative for this study since 
this organism is equally easy and cheap to handle. Interestingly this organism does 
not have a homologue of the protein of interest, therefore the idea was dismissed. In 
addition to these advantages of A. nidulans mentioned above, it was also important 
that all the methods such as genetic transformation and targeted gene replacement 
were described in the 80’s and 90’s which obviously made all manipulations easier 
because the establishment of such studies and protocols is also quite time consuming 
and hard to deal with. Moreover the A. nidulans has always played an important role 
in the genetic dissection of the cell cycle. And last, but not the least, the experience 
and expertise of Dr. Diallina’s laboratory was an extra stimulus for us to conduct our 
experiments on A. nidulans.  
1.4.5. Aim 
Our aim in this study was firstly to characterize the loc115098 gene. For this purpose 
we designed experimental approaches for both the human cell lines and the 
filamentous fungus A. nidulans. Our initial observations which will be explained in 
the ‘Results’ pointed that Loc115098 could be involved in mitosis and therefore we 
concentrated on the cell cycle regulation and the possible participation of Loc115098 
into this process. Since loc115098 is a newly identified gene, its features, function 
and any related data were still elusive. Our aims in this study were focusing on the 
identification of such data by utilizing as many tools and approaches as possible. 
Therefore we concentrated on a) localization, b) over expression, c) knock-out 
studies as well as the bioinformatics analyses of this new gene. The idea 
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behind all these approaches was firstly to understand the characteristics of 
Loc115098 and to check its expression profile and correlate it with the data coming 
from the bioinformatics analyses. In addition to this, we sought to identify the 
subcellular localization of this protein and to observe any phenotypical changes 
caused by the overexpression and/or the knock-out of the gene. 
The subcellular localization studies were mainly focusing on the determination of the 
localization of Loc115098 protein in the cell. It might be crucial to understand where 
this protein localizes in the cell because it might give us a clue about the possible 
Loc115098 interacting proteins. In the overexpression studies; our aim was to 
observe the possible differences in the phenotype of the cells which were caused by 
the increase in loc115098 or AN0879.3 expression. The results coming from this 
experiment would lead us to conduct some microscopic or biochemical analysis to 
observe and understand these changes in a better way. Lastly, our knock-out strategy 
was set in order to be able to observe the possible outcomes of the deletion of 
AN0879.3.  
Certainly, all the results obtained from our already designed approaches would bring 
new aspects for the current project. This study was a part of our long term attempt to 
functionally characterize loc115098. 
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2. MATERIALS AND METHODS 
2.1. Bioinformatics 
2.1.1. Data bases 
The accession number of human loc115098 in the NCBI database 
(http://www.ncbi.nlm.nih.gov) is NM138442. The same sequence can also be 
obtained from Genome Browser database at the University of California Santa Cruz 
(Kent et al., 2002) with the accession number of LOC115098. The Zebrafish 
loc115098 can also be found in NCBI with the accession number of BC066532. The 
A.nidulans copy of loc115098 which we call AN0879.3 can be found in the 
A.nidulans database prepared by Broad Institute: 
(http://www.broad.mit.edu/annotation/genome/aspergillus_nidulans/Home.html). 
The accession number for Loc115098 protein is AN0879.3; the mRNA data can also 
be reached and the exons and the introns of the gene can optionally be viewed. In 
order to find the homologues of loc115098 in different organisms generally the 
NCBI Blast (Altschul et al., 1990; Altschul et al., 1997) search was utilized. 
2.1.2. DNA analysis  
Once the sequences of different organisms were obtained, they were not only used 
for further studies such as amplification and cloning but also for performing some 
bioinformatical sequence comparisons. For these comparisons mainly the ClustalW 
(Higgins, 1994) (http://www.ebi.ac.uk/clustalw/#) was used.  
When loc115098 was firstly identified the annotation for the human sequence was 
obtained from the Genome Vista database (Couronne et al., 2003), and the sequences 
were aligned with the mVista too (Frazer et al., 2004) (Hani Alotaibi unpublished).  
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2.2. Plasmids and Cloning 
The plasmids which were used for localization studies in human cell line MCF-7 
were p3XFLAG-CMV-10 (Sigma) and p3XFLAG-CMV-14 (Sigma). The plasmids 
which were used for A. nidulans studies were pBKS (Stratagene) and pGEM-T 
(Promega). All plasmids had ampicillin resistance. 
The standard protocol for cloning was to double digest both the plasmids and the 
inserts which have already been amplified with the appropriate enzyme and reaction 
conditions. This was followed by a ligation step and later the ligated plasmid was 
transformed into E.coli DH5α strain. After that the plasmids were rescued from the 
bacteria. Then several further digestions and PCR analyses were carried out in order 
to obtain the plasmid carrying the gene of interest. 
The enzymes used for this purpose and their reagents were as following:  
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Table2.1. The restriction enzymes which were used for the cloning and plasmid 
confirmation purposes. 
RESTRICTION ENZYMES 
Name Temperature Buffers 
BamHI 37ºC 
10mM Tris-HCl (pH 8.0 at 37°C),  
5mM MgCl2,  
100mM KCl, 
0.02% Triton X-100, 
1mM 2-mercapthoethanol, 
0.1mg/ml BSA 
BglI 
SalI 37ºC 
50mM Tris-HCl (pH 7.5 at 37°C),  
10mM MgCl2,  
100mM NaCl,  
0.1mg/ml BSA 
EcoRI 37ºC 
50mM Tris-HCl (pH 7.5 at 37°C),  
10mM MgCl2,  
100mM NaCl, 
0.02% Triton X-100, 
0.1mg/ml BSA 
HindIII 37ºC 
10mM Tris-HCl (pH 8.5 at 37°C),  
10mM MgCl2,  
100mM KCl,  
0.1mg/ml BSA 
KpnI 37ºC 
10mM Tris-HCl (pH 7.5 at 37°C),  
10mM MgCl2,  
0.02% Triton X-100,  
0.1mg/ml BSA 
NcoI 37ºC 
DpnI 37ºC 
SmaI 30ºC 
XbaI 37ºC 
33mM Tris-acetate (pH 7.9 at 37°C),  
10mM magnesium acetate,  
66mM potassium acetate, 
0.1mg/ml BSA 
 
The p3XFLAG-CMV-10 was basically used for N-terminus tagging of Loc115098. It 
was firstly double digested by XbaI and HindIII enzymes. The Loc115098 was 
amplified by the primers called HALNG-F1 and HALNG-R1 and these two 
fragments were ligated in appropriate conditions and the transformation was carried 
out. The p3XFLAG-CMV-14 was digested by BglI and HindIII enzymes and the 
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PCR product of Loc115098 was obtained by using the primers called HALNG-F1 
and LOC-HN-Ctrev. Later the same ligation and transformation protocol was carried 
out. Several enzyme digestions were done to confirm the correct plasmid.  
 
Figure2.1. The vector maps of plasmids which were used to construct the N and C-
termini FLAG epitope tagged Loc115098. The p3XFLAG-CMV-14 was double 
digested with BglI and HindIII and Loc115098 was inserted between these 2 sites 
with the same linkers. The p3XFLAG-CMV-10 was double digested with XbaI and 
HindIII and Loc115098 was cloned in between these two sites with the same linkers.  
The pALC plasmid was kindly provided by Dr V. Sophianopoulou’s group. The 
plasmid was already carrying the alcA promoter cloned in the polyT site of the 
plasmid. Thus we inserted the AN0879.3 carrying NcoI linker on both sides into 
NcoI digested pALC. After the ligation and E. coli transformation steps the 
orientation of AN0879.3 in the plasmid was further confirmed by PCR. Later the 
argB selection gene was cloned into the same plasmid with EcoRI sites. After all the 
cloning steps this plasmid was named pALCLOC. This plasmid was transformed into 
each strain by the method which is explained in detail in the methods section. 
Following the transformation the transformants were grown on CM in Petri dishes 
and they were checked whether or not they were carrying our gene of interest 
together with alcA promoter in the correct orientation by PCR. The correct 
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orientation meant that the AN0879.3 was intact with the promoter, confirming that it 
is under the control of this promoter. Later the copy number of these transformants 
was detected by Southern Blot analyses and the ones carrying multi copy were 
further studied. 
 
Figure2.2. The vector map of pGEM-T Easy plasmid which was used for 
overexpression studies. 
2.2.1. Site directed mutagenesis 
After cloning A. nidulans homologue of loc115098 into the pBSK, the stop codon of 
AN0879.3 was destroyed by site directed mutagenesis by using the primers called 
‘McaP no-stop NcoI FOR’ and ‘McaP no-stop NcoI REV’. For this reaction Phusion 
High Fidelity DNA polymerase (Finnzymes) was used according to its manual. After 
the PCR amplification this product was digested by DpnI enzyme for 1,5 hours. After 
that it was transformed into E.coli DH5α. 
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2.3. Primers  
Table2.2. The primers which have been used concerning the current study. 
Name Sequence 5' →3' Expected Size
Locus Expression Primers
EKYG F2 GAGGAGGAGGACTCCAAGCTC
EKYG R2 CTGGGCTTCCTCAAAGGC
F1-ZFYGxp ACCAAAGGCTTTTGGAGG
R1-ZFYGxp GTTGGCTTCTTCAAACGC
GAPDH-F GGCTGAGAACGGGAAGCTTGTCAT
GAPDH-R CAGCCTTCTCCATGGTGGTGAAGA
Locus Cloning Primers
HALNG-F1 GAATTCAAGCTTATGCCCAAGAAGTTCCAG
HALNG-R1 GGATCCTCTAGAGCTCACTTGGGGGCATTG
HALNG-F1 GAATTCAAGCTTATGCCCAAGAAGTTCCAG
LOC-HN-Ctrev GATATCAGATCTGCCTTGGGGGCATTGAAGGGC
McaP Forward NcoI CGCCATGGGCGGCAAAAAGGGC 
McaP Reverse NcoI CGCCATGGTGCTGAGCGCGAGCTATG 
5’ FOR KpnI GCGGTACC-TATCGAATGGCCAATTCC
5’ REV EcoRI GCGAATTC-AGGTGAATGAGGCTTGTC
3’ FOR EcoRI CGGAATTC-TGAGGATTGGAAGGACTG
3’ REV XbaI CGTCTAGA-GTGGATGATAGTGCACGA
Pyr4 FOR EcoRI CGGAATTC-AAGCTTAGACTTCAACAA
Pyr4 REV EcoRI CGGAATTC-GGATCTTCATCATTCGTC
5 ∆McaP Fo GATTCGCACAGACAGCCATAG
5 ∆McaP Re GTCTTCACCTCGTAGGGGATG
3 ∆McaP Fo CATCCCCTACGAGGTCAAGAC
3 ∆McaP Re CGCTGCATCATAGCTGAGAC
CPFP4Fo CACAAGAAACGGACAAGAAGGTCTGAAAAGCTTAGACTTCAACAACCCCACCATC
CPFP4Re TAAAACACAATCATTATGTAAACAAATCATGGATCTTCATCATTCGTCGCTTTCGGG
CPF5Fo GCAAGTCTTAGCGAGTG
CPF5Re GATGGTGGGGTTGTTGAAGTCTAAGCTTTTTCAGACCTTCTTGTCCGTTTCTTGTG
CPF3Fo CCCGAAAGCGACGAATGATGAAGATCCATGATTTGTTTACATAATGATTGTGTTTTA
CPF3Re GCCAGTCTGTGTGAAGT
PNPCRFo CGTGGAACACCTTACTC
PNPCRRe GAAACTCTCGCTGGACA
McaP upstream BamHI GCGGATCCTGATCGGGGAGGGTAGCA 
McaP downstream EcoRI CCGGAATTCTGCTGAGCGCGAGCTATG 
McaP no-stop NcoI FOR GCGAGACTCACGAGGTCCATGGTTTGTTTACATAATGATTG
McaP no-stop NcoI REV CAATCATTATGTAAACAAACCATGGACCTCGTGAGTCTCGC
GFP NcoI linker FOR GGCCATGGTAATGGTGAGCAAGGGCGA
GFP NcoI linker REV CGCCATGGTTACTTGTACAGCTCGTCC 
Conditional Knock-out Primers
ALCMcaP For+ GACAAGCCTCATTCACCTGAATTCGCGAGCTACCATCCAATAACCCCCAGCTG
ALCMcaP Rev+ GTTGAAGTCTAAGCTTGAATTCCGGGATGAACCGACATACAGAATAAGTGAC
site directed mutagenesis
745bp
1371bp
3699bp
1985bp
3160bp
6200bp
pLOCGFP Construction Primers
Double-Joint PCR Primers
Knock-out Cloning Primers
pALCLOC Conctruction Primers
1859bp
3013bp
1337bp
2034bp
2149bp
1859bp
4087bp
667bp
318bp
314bp
143bp
672bp
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2.4. Cell Culture 
2.4.1. Cell lines 
In order to check the expression profile of Loc115098 several hepatic and mammary 
gland cell lines were used. The hepatic cell lines were HepG2, Hep40, SNU182, 
SNU387, SNU398, SNU449, Huh7, and Focus. The mammary gland cell lines are 
which were used were BT474, BT20, T47D, MCF7, 453, 468, HME, HCC, 231. The 
cDNAs of these cell lines were all kindly provided by Prof Mehmet Ozturk’s group.  
2.4.2. Growth Media 
MCF-7 cell line were maintained in high glucose Dulbecco’s modified Eagle’s 
medium (Gibco) [supplemented with 10% fetal bovine serum (FBS), 1% 
penicillin/streptomycin (P/S) and 1% L-glutamine (Biochrom)], abbreviated as 
DMEM, at 37°C in a 5% CO2 incubator. 
2.4.3. Transfection 
The transfection of MCF-7 cells was carried out with plasmids by using FuGENE 
reagent (Roche). Cells which were 90%-100% confluence in 100 mm dishes were 
harvested by trypsinization and washed once with DMEM (not containing the FBS, 
penicillin/streptomycin and L-glutamine) then resuspended in 10 ml DMEM, and 
diluted 1:7 in culture medium (3 ml cells in 20 ml medium), diluted cells were then 
seeded in 24-well plates for transfection; 400 µl cells per well. 
2.4.4. cDNA synthesis and RT-PCR 
The cDNAs of the cell lines were kindly provided by Dr Mehmet Ozturk’s group 
whereas the cDNAs of Danio rerio (Zebrafish) were kindly provided by Dr Ozlen 
Konu’s group and the cDNAs from human brain tissues were again kindly provided 
by  Dr Cengiz Yakicier’s group. In order to perform cDNA synthesis 2µg of RNA 
was used and the reaction was done according to the Revert-Aid First Strand cDNA 
Synthesis Kit (Fermentas) manual. The rat tissue RNAs were isolated by Dr Hani 
Alotaibi and the cDNA synthesis was performed by using 2µg of these RNAs. After 
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the PCR amplifications the PCR products were resolved on 2% agarose gels stained 
with ethidium bromide and visualized using the Gel Doc-2000 supported with the 
Multi-Analyst Ver.1.1 image analysis software (Bio-Rad). 
Table2.3. The PCR Polymerase enzymes which have been used for this study. 
Company Name Reagents
Stratagene Platinum Pfx DNA Polymerase 1xbuffer,0.3mM dNTPs each,1mM MgSO4,0,3µM each primer,1Uenzyme
Finnzymes Phusion 1xbuffer,200µM dNTPs each,0,3µM each primer,1Uenzyme
Finnzymes DyNAzyme EXT DNA Polymerase 1xbuffer,360µM dNTPs each,0.3µM each primer,3Uenzyme
HyTest HyTest Taq Polymerase 1xbuffer,0.3mM dNTPs each,1mM MgSO4,0,3µM each primer,1Uenzyme
Roche Taq DNA Polymerase 1xbuffer,0.3mM dNTPs each,1mM MgCl2,0,3µM each primer,1Uenzyme
PCR ENZYMES
 
2.5. Aspergillus nidulans handling 
2.5.1. Strains 
Several different strains were used in this study. There were some wild-type strains 
(pyrG89 paba panto, pyrG89 argB2 paba panto) as well as some cell cycle mutant 
strains SO6 (nimA5, wA2, pyrG89, cnxE16, choA1, yA2, chaA1, sC12), DBE4 
(bimE7, riboA2, pyrG89) which were kindly provided by Dr. S. Osmani and 8-16(1-
3) (riboA1, wA3, bimD6, pyroA4, sudD7), 8-16(3-6) (pyrG89, [bimD6?], pyroA4, 
sudD7) which were kindly provided by Dr G May and Dr S Osmani. 
2.5.2. Growth Media 
The complete medium (CM) and minimal medium (MM) for A. nidulans have been 
described previously by Tilburn et al., 1983; Cove, 1966.  
2.5.2.1. Complete Medium (CM) 
Vitamin solution 10 ml 
Salt solution  20 ml 
Casamino acids 10 ml  
D-glucose  10 gr 
Bacto-peptone  2 gr 
Yeast Extract  4 gr 
Agar   30gr (3%) 
pH adjusted to 6.8 and filled with dH2O to 1 liter 
  
22
Vitamin Solution 
20 mM p-amino benzoic acid, 1mM Biotin, 0,1M Nicotinic acid, 50 mM Calcium-D-
pantothenate, 0,1M Riboflavin, 50mM Pyridoxine, 50mM Thiamine filled with dH2O 
to 1 liter 
Salt Solution  
26g KCl, 26g MgSO47.dH2O, 76g KH2PO4, 50ml trace elements, 2ml chloroform 
filled with dH2O to 1 liter 
2.5.2.2. Minimal Medium (MM) 
20ml salt solution, 10g D-glucose, pH adjusted to 6.8 and filled with dH2O to 1 liter 
2.5.2.3. Fructose Medium (FM) 
0,1g fructose, 2ml salt solution, 2g agar, pH adjusted to 6.8 and filled with dH2O to 1 
liter 
2.5.2.4. Sucrose Medium (SM) 
20ml salt solution, 342,3g sucrose, 10g glucose, 2% agar pH adjusted to 6.8 and 
filled with dH2O to 1 liter 
2.5.3. Growth tests 
After each transformation and when the phenotypic observations were needed to be 
made, we performed the growth tests. Basically different strains or different 
transformants were inoculated on either CM or MM which contained the appropriate 
oxotrophies and usually grown at different temperatures in parallel to observe the 
changes. 
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2.5.4. Transformation 
Transformations were made with protoplasts of mycelia from the appropriate strains. 
The transformation was essentially as described by Tilburn et al., 1983 (Tilburn et 
al., 1983). The routine protocol was adapted from M.Koukaki et al., 2003 (Koukaki 
et al., 2003). Aspergillus strains were grown on CM for 3-4 days at various 
temperatures depending on the strain. From these Petri dishes the conidiospores were 
taken by carefully scraping the dish into 5 ml dH2O containing falcon and they were 
separated from mycelia by filtration through sterile blutex. Afterwards, 1010-11 
conidiospores were inoculated in MM, supplemented with 5mM urea as a nitrogen 
source, necessary vitamins and either 5mM arginine (argB2 strains) or 10mM uracil 
and uridine (pyrG89) or both (argB2 and pyrG89) for 3,5-4 (7 hours for nimA5) 
hours at the appropriate temperature at 130rpm. Upon the initiation of the 
germination, the conidiospores were collected with centrifugation at 4000rpm for 10 
minutes and resuspended in 10 ml of the standard isosmotic buffer (Tilburn et al., 
1983). In order to start the protoplastation, Glucanex (Novozymes) was added in the 
concentration of %90 (m/v) and it was incubated at 30ºC for 1,5 hour to let it act. 
After the completion of protoplastation conidiospores protoplasts were washed twice 
in 1M Sorbitol, 10mM Tris-HCl, and 10mM CaCl2 pH 7.4, resuspended in the same 
buffer at a concentration 108 conidiospores/200µl and distributed into sterile 
eppendorfs. Each eppendorf was used for a single transformation experiment with 
0.5µg of plasmids. After the mixing the appropriate plasmid with the conidia 
protoplasts, a drop of PEG was added on top and it was chilled on ice for 15 minutes 
before adding the 500µl PEG. They were incubated at room temperature for 15 
minutes and then centrifuged for 10 minutes at 6000rpm. After the centrifugation 
they were washed with the above mentioned solution, they were again centrifuged at 
5000rpm for 4 minutes and later they were plated on SM and allowed to grow for 3-4 
days at various temperatures depending on the strain.  
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2.5.5. DNA Extraction 
The DNA isolation protocol was previously described by Lockington et al., 1985 
(Lockington et al., 1985). The strains were inoculated and grown overnight in 50ml 
MM containing the appropriate vitamins and urea as a nitrogen source at distinct 
temperatures depending on the strain at 130rpm. The next day mycelia were 
collected by filtering through blutex and they were firstly kept at -80ºC for 10 
minutes. Later they were homogenized by mortar and pestle in liquid nitrogen. An 
aliquot of 100-200mg was kept in an eppendorf and 800µl breaking solution (Tris-
HCl pH8 0,2M; SDS 1%; EDTA pH8, 1mM) was added to further break the cells. 
Then it was vortexed vigorously and kept on ice for 20 minutes. Later phenol 
chloroform extraction was carried out.  
2.5.6. RNA Extraction 
The strains were inoculated and grown overnight in MM containing the appropriate 
vitamins and urea as a nitrogen source at distinct temperatures depending on the 
strain at 130rpm. All the materials that were used for RNA extraction were RNase 
free. The next day mycelia were collected by filtering through blutex and they were 
firstly kept at -80ºC for 10 minutes. Later they were homogenized by mortar and 
pestle in liquid nitrogen. An aliquot of 100mg was kept in an eppendorf and 1ml of 
trizole was added together with 10mg of glass beads. It was vortexed vigorously and 
kept at room temperature for 10 minutes. Then it was centrifuged at 4ºC for 15 
minutes at 12000rpm. The supernatant was taken into a clean eppendorf and 200µl of 
chloroform was added, it was shaken by hand and incubated at room temperature for 
2 minutes. The centrifugation was repeated with the same conditions. After the 
centrifugation the upper phase was transformed into a new clean eppendorf. 500µl 
isopropanol was added on top of it and it was chilled on ice for 10 minutes after 
shaking the eppendorf well. After the centrifugation at 4ºC for 10 minutes at 
12000rpm the supernatant was discarded and the pellet was washed by 1 ml of 75% 
Ethanol. After the washing step the pellet was dried and resuspended in DEPC 
treated dH2O.  
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2.5.7. Southern Blotting 
The nucleic acid manipulations were done according to the previously prepared 
protocols by Sambrook et al. After the DNA extraction step, the concentration was 
measured by Optic Density (OD) measurements. 2,5-3µg of DNA was digested by 
EcoRI for 2 hours at 37ºC and then more enzyme was added and the digestion was 
carried out overnight. The next day 1% agarose gel was prepared to run the digested 
fragments in 1xTAE (242g Tris base, 57.1ml Glacial Acetic Acid, 18.6 g EDTA in 1 
lt dH2O). The electrophoresis was done at 58V for 4 hours. After the completion of 
the electrophoresis the gel picture was taken. The gel was baked at 100% Ultraviolet 
light (254nm) for 5 minutes and the irrelevant parts of the gel was cut and discarded. 
Then the baked gel was incubated in denaturing buffer (0,5M NaOH and 1,5M NaCl) 
for half an hour. Then the gel was incubated in the neutralizing solution (1M Tris-
HCl pH 8 and 1,5M NaCl) for half an hour. After these steps the overnight capillary 
transfer was carried out in alkaline conditions using the sandwich method. It is called 
sandwich because the gel and the membrane are kept together between two layers of 
Whatman paper. It is necessary for the capillary movement. 20XSSC (0,3 M 
Na3C6H5O7.2H2O and 3M NaCl pH 7) was used for the transfer. In the sandwich 
method, firstly the long Whatman No:2 papers were placed in such a manner that 
both ends of the paper could be deep in the transfer buffer. The gel was placed on top 
of the Whatman papers. The edges of the gel were wrapped by plastic wrap so as to 
let the capillary movement continue through the gel and the membrane. On top of the 
gel the nylon membrane was placed and it was made sure that there were no air 
bubbles left in between the gel and the membrane. 2 pieces of Whatman paper were 
cut in the same size as the membrane and wetted in 2X SSC then they were placed on 
top of the membrane. The air bubbles were smoothened out by a glass rod. A stack of 
paper towels (5-8 cm) were placed on the Whatman papers and lastly a 500-g weight 
was placed on top of all. The tissue papers were changed as they became wet. The 
transfer was carried out for at least 20 hours. Following the transfer the membrane 
was cross linked by UV light. Then it was ready for hybridization. 
For the hybridization step Church buffer (0,15M BSA; 0,5M orthophosphate; 1mM 
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EDTA; %20 SDS and dH2O) was used. After placing the membrane in a cylinder 
with 100ml of Church buffer the pre-hybridization step took place where the 
membrane was incubated at 65ºC for 2 hours. Meanwhile the [32P]dCTP labeled 
probe was prepared using a random hexanucleotide-primer kit following the 
supplier’s instructions (Promega). After the prehybridization, the probe was added in 
the cylinder and the hybridization was initiated by leaving the membrane for 
incubation at 65ºC overnight. The next day probe containing church buffer was 
removed and the washing steps were carried out. The washings were as following: 30 
minutes at 65ºC in 2xSSC, 0.1% SDS twice and in the cylinder. After that 30 minutes 
at 65ºC in 1xSSC, 0.1% SDS in a plastic container. Once the washing was completed 
the membrane was placed in a light-proof cassette with a film on and it was kept at -
80ºC for a period ranging from 3hours to 7 days (depending on how strong the probe 
is). The development was made manually by using developer and fixer solutions. 
2.5.8. Northern Blotting 
The nucleic acid manipulations were done according to the previously described 
protocols by Sambrook et al. Once the RNA extraction was completed the OD 
measurement was carried out. All the materials were either RNase free or made 
RNase free manually by adding DEPC treated water or NaOH washings when 
necessary. Firstly the running buffer (10mM orthophosphate) was prepared which 
was used both for electrophoresis and the preparation of the agarose gel. 10µg RNA 
was mixed with the following mixture; for x volume of RNA, 3x volume of 11,5µl 
DMSO; 2,25µl (0,1M pH7) orthophosphate; 3,3µl glyoxal. This mixture was 
incubated at 50ºC for one hour and then on ice 5 minutes. After the 1% agarose gel 
was ready, and the incubation on ice was over, the samples were ready to be loaded 
after adding the dye (10mM orthophosphate, 2%Bromophenol blue, 50% glycerol) to 
a final ratio of 1/8 of the total volume. After the loading of the samples, the 
electrophoresis was carried out. The voltage was adjusted according to the distance 
between the two electrodes; it was carefully calculated to 3V per centimeter. After 
letting the samples run for 5 minutes, the peristaltic pump was started to keep the 
currency stable (maximum 60mA). The samples were allowed to run for 5 hours and 
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once the electrophoresis was over the transfer was ready to be started. The sandwich 
model was prepared as described in the ‘Southern Blotting’ section. The transfer was 
carried out in 20X SSC overnight. Next day the membrane was baked under UV for 
5 minutes and then it was stained with methylene blue dye (0,5M NaOAc pH: 5.2 
with 0,03% methylene blue) for 2 minutes and a picture was taken. After that the 
membrane was soaked into the destaining buffer (1% SDS; 0,2X SSC) until there 
was no stain left on the membrane. After the destaining, the membrane was ready to 
be hybridized. The hybridization was the same as it was described in ‘Southern 
Blotting’ section. The washings were as following: 10 minutes at 65ºC in 100 ml of 
2xSSC, 0.1% SDS twice and in the cylinder. After that, 20 minutes at 65ºC in 200 ml 
of 1xSSC, 0.1% SDS in a plastic container. Once the washing was completed the 
membrane was placed in a light-proof cassette with a film on and it was kept at -80ºC 
for a period ranging from 3hours to 7 days (depending on how strong the probe is).  
The development was made manually by using developer and fixer solutions.  
2.6. Immunofluorescence (IP)  
The localization studies which were performed with MCF-7 cell line were carried out 
as following: Firstly the cells were grown on cover slips in 8-well plates and when 
they became confluent the cover slips were removed from the cell culture dish and 
they were treated with 4% paraformaldehyde at room temperature for 15 minutes. 
After that the cells were treated with 1:1000 TritonX-100 in PBS for 6 minutes at 
room temperature. The blocking was performed by blocking solution (5% BSA in 
PBS) for 1 hour at room temperature. Later ANTI-FLAG M2 monoclonal antibody 
(Sigma) was applied to these cover slips. They were kept in this antibody diluted in 
blocking solution (20µg/ml) for one hour in a dark place. Afterwards they were 
washed 3 times in 1xPBS. Then they were kept in anti-Texas Red antibody which 
was diluted in blocking solution (1:200) for one hour at room temperature in a dark 
place. The washing step was repeated and then the counter stain HOESCHT (1:1000) 
was applied for 5 minutes. Following the washing step the cover slips were mounted 
by glycerol and they were ready for visualization. 
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2.7. Microscopy 
In the subcellular localization studies which were performed by using A.nidulans the 
samples were prepared as following. Initially the cover slips were washed in nitric 
acid, water and aceton and later poly-L-lysine hydrobromide (Sigma) was applied on 
each cover slip. Later two of these clean and poly-L-lysine hydrobromide treated 
cover slips were placed in sterile Petri dishes. Following the addition of the medium 
into the dish, the appropriate strains were inoculated and they were allowed to grow 
at either their permissive or restrictive temperature. When the strains were grown 
according to their growth rate, the cover slips were removed from the petri dish and 
the fixation and staining step took place according to Harris et al., 1994 (Harris et al., 
1994) and May et al., 1992 (May et al., 1992b). After removing the cover slips from 
the petri dish firstly the fixation buffer (3.7% formaldehyde, 50mM phosphate buffer 
pH 7, 0.2% TritonX-100) was applied to the cover slips. They were incubated at 
room temperature in a dark for 20 minutes and then they were then washed in dH2O, 
later the stains were applied. For the staining of the nucleus DAPI (4,6-diamidino-2-
phenylindole, dihydrochloride) and for the staining of the cell wall calcofluor were 
used. They were incubated in these dyes for 10 minutes and then rinsed in dH2O. The 
cover slips were then mounted on slides which had 20µl mounting buffer (10% 
phosphate buffer, 50%glycerol and dH2O) and they were ready for microscopic 
analyses. The photographs were taken by Axionplan Zeiss phase-contrast fluorescent 
microscope and appropriate filters. 
The photographs of MCF-7 cells were taken by AxioCamMRm Zeiss fluorescent 
microscope.  
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3. RESULTS 
3.1. Computational Data about Loc115098 
3.1.1. The identification of loc115098 
As it was explained in the introduction section, Loc115098 was firstly identified in 
an unrelated study where cis-acting transcriptional elements of the NIS (Sodium-
Iodide Symporter) gene were being analyzed. The focus of that study was to analyze 
a putative transcriptional control element localized in the 3’ downstream of NIS gene 
by using a tool called VISTA (Negre et al., 2005). Loc115098 was one of the 10 
conserved putative regions identified. (Alotaibi et al, unpublished data). (See Figure 
3.1) 
 
 
Figure 3.1. VISTA plot of conservation levels in a 90 kbp genomic DNA in human, 
mouse and rat. Only the 10th region is shown here. Percent nucleotide identities 
between human, mouse and rat DNA sequences are plotted as a function of position 
along the human sequence. Peaks of evolutionary conservation in overlapping exonic 
sequences are shaded blue. Aligned regions of more than 50% identity over 75 bases 
are shaded pink. (Alotaibi et al., unpublished) 
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3.1.2. Features  
According to our computational analyses, the human Loc115098 is located in 
chromosome 19p22. The gene consists of 4 exons and the predicted protein is 223 
amino acid-long. It has rather an unusual amino acid composition and it is very 
hydrophilic. 42% of the protein consists of charged amino acids such as Arginine, 
Lysine, Aspartate and Glutamate. Therefore it is a very basic protein (pI=10). It bears 
no domain similarities with any previously known proteins. The conservation of 
Loc115098 is remarkably high. Our in silico analysis through the databases has 
proved that it is conserved in the eukaryotic kingdom with the exception of the 
budding yeast Saccharomyces cerevisiae. Although the similarity ratios differ, there 
is more than 75% identity in mammals, 50% identity with insects and nematodes and 
30-40% identity with plants and ascomycetes.  
In the simplest possible model organism A.nidulans, the gene is located on the 8th 
chromosome, Contig 14: 46513-47339 +. It has the ID number of AN0879.3 and can 
be reached at the Broad Institute web page with the same accession number. 
(http://www.broad.mit.edu/annotation/genome/aspergillus_nidulans/Home.html). 
The Aspergillus and human homologue of this protein had a 34.4% identity. 
However the Aspergillus homologue was 222-amino acid long but the composition 
of the amino acids showed similar features. (See Figure 3.9) 
3.1.3. Post Translational Modifications 
Aiming to better understand this unusual protein carrying no domain similarities with 
other proteins, we also searched for the post translational modifications through 
Expasy/Prosite webpage (http://www.expasy.org/prosite/). The results of this study 
indicated that both the human and the Aspergillus homologues had several predicted 
post translational modifications. Both of them had predicted Tyrosine kinase, protein 
kinase C, casein kinase II, cAMP and cGMP dependent protein kinase 
phosphorilation sites, N-myristoylation sites. In addition, the Aspergillus copy has an 
amidation site and an alanine rich region in the C-terminus and the human copy has 
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an extra tyrosine sulfation site. Moreover, they both carry bipartite nuclear targeting 
sequence in the C-terminus of the protein. All of these post translational modification 
predictions might be very important and we intend to further investigate these 
modifications in near future. 
3.1.4. Biological Significance of Loc115098 
Our bioinformatics analyses have indicated that loc115098 is an evolutionarily 
conserved gene suggesting that it exists in all eukaryotic kingdom. We believe that, 
this high percentage of conservation might be pointing at a biological significance. 
All genes which are very well conserved during evolution have important functions 
in crucial biological events. Among the most conserved genes, the histones are best 
known examples. 16S RNA which is a subunit of ribosomal RNA is another example 
of the conserved genes which also has an essential role for the organism. Along with 
this proof we hypothesize that loc115098 could be playing an important role in one 
of the well conserved biological mechanisms such as mitosis.  
3.2. Analysis of Loc115098 Expression in Different Tissues 
After the identification of loc115098, the aim of the study was initially to confirm 
that loc115098 is expressed in different tissues of different organisms. For this 
purpose several tissues were investigated whether or not they expressed the 
loc115098 gene. 
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3.2.1. Breast cell lines  
Firstly, the expression pattern of cDNAs of hepatic cell lines was analyzed. Here we 
confirm that the appropriate primers are able to amplify the loc115098.  
    
 
 
 
 
 
Figure3.2. The mammary gland cell lines were grown in DMEM with the appropriate 
supplements and RNA was prepared. Then the expression of loc115098 was 
evaluated by RT-PCR. GAPDH was used as an internal control to verify the equal 
loading of wells. It was confirmed that Loc115098 is expressed by all mammary 
gland cell lines analysed. 
 
3.2.2. HCC cell lines 
 
 
 
 
 
Figure3.3. The hepatic cell lines were grown in DMEM with the appropriate 
supplements and RNA was prepared. Then the expression of loc115098 was 
evaluated by RT-PCR. GAPDH was used as an internal control to verify the equal 
loading of the synthesized cDNA. It was confirmed that Loc115098 is expressed by 
all hepatic cell lines analysed. 
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3.2.3. Human brain tissues and Mouse tissues 
After the confirmation of Loc115098 expression in several breast and HCC cell lines, 
we also analyzed the expression profile of Loc115098 in human brain tissues, kindly 
provided by Dr Cengiz Yakicier’s group. Meanwhile with the same purpose we 
synthesized cDNAs of the already existing RNAs which were extracted from several 
rat tissues by our group. The results indicated that these tissue types also had a 
persisting Loc115098 expression. (See Figure 3.4)  
 
 
 
 
 
Figure3.4 A) The cDNAs from human brain tissues indicate the persistent expression 
of Loc115098. B) RNA was isolated from the mammary gland, liver, thyroid and 
stomach tissues were isolated of rat and the expression of loc115098 was analysed by 
RT-PCR. GAPDH was used as an internal control to verify the quality of the 
synthesized cDNA. It was confirmed that Loc115098 is expressed in all tissues. 
(MG: Mammary gland). 
3.2.4. Zebrafish tissues 
To further extend our expression studies on Loc115098, we also designed primers to 
confirm Loc115098 expression in zebrafish tissues. The cDNAs and Mipep primers 
were kindly provided by Dr Ozlen Konu’s group. Mipep is a gene which is used as 
an internal control in this study. cDNAs were synthesized from different growth 
stages as well as from several tissues. Our results indicated that Loc115098 is 
expressed in pectoral fin, dorsal fin, ovary, but not in heart, gills, muscle and liver. 
Following zebrafish through embryonic development, we observed the first 
Loc115098 expression at the 24th hour post fertilization whereas later the expression 
could not be observed neither at the 48th hour nor on the 3rd day post fertilization 
however it could again be observed on the 4th, 5th and 6th day post fertilization. 
A) Human brain tissues B) Rat tissues
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Figure3.5. The expression of loc115098 was evaluated by RT-PCR. Mipep was used 
as an internal control to verify the quality of the synthesized cDNA. (8hpf:8th hour 
post fertilization, 4dpf: 4th day post fertilization, PF: pectoral fin, DF: Dorsal fin, DT: 
Ductal track) 
3.3. Subcellular Localization of Loc115098 in MCF-7 Cell Line 
Once we confirmed that Loc115098 has a persistent expression profile in different 
cell lines and tissues, we set a new goal to identify the subcellular localization of 
Loc115098 protein. For this reason we firstly prepared two constructs, one carrying a 
C-terminus and the other N-terminus flag epitope tagged Loc115098. In these two 
different plasmids, Loc115098 was cloned either in the C-terminus or in N-terminus 
of 3XFLAG protein expressing sequence. Then we transfected these constructs into 
MCF-7 cell line, separately. 
3.3.1. Construction of pFLAGLOC and pLOCFLAG plasmids 
The p3XFLAG-CMV-10 was used for N-terminus tagging of Loc115098. It was 
firstly double digested by XbaI and HindIII enzymes. The Loc115098 was amplified 
by the primers called HALNG-F1 and HALNG-R1 and these two fragments were 
ligated in appropriate conditions and the transformation was carried out. The 
p3XFLAG-CMV-14 was digested by BglI and HindIII enzymes and the PCR product 
of Loc115098 was obtained by using the primers called HALNG-F1 and LOC-HN-
Ctrev. Later the same ligation and transformation protocol was carried out. Several 
enzyme digestions were done to confirm the correct plasmid. (See Figure 3.6) 
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Figure3.6. The plasmids which were used to construct the N and C-termini FLAG 
epitope tagged Loc115098. In figure A, the p3XFLAG-CMV-14 was double digested 
with BglI and HindIII and Loc115098 was inserted between these 2 sites with the 
same linkers. In figure B, the p3XFLAG-CMV-10 was double digested with XbaI 
and HindIII and Loc115098 was cloned in between these two sites with the same 
linkers.  
3.3.2. Ectopically expressed loc115098 is likely to involve in mitosis 
When N and C-termini FLAG tagged Loc115098 was transfected into the MCF-7 
cell lines, together with the HOESCHT-33252 staining we observed that Loc115098 
protein is very likely to involve in cell cycle regulation, because as shown in the 
figure 3.7 when cells are not dividing Loc115098 is localized in the cytoplasm 
whereas it is relocated to the nucleus upon the initiation of mitosis. In this figure it is 
clearly observed that the cells which are pointed with arrows in A’ representing those 
that express N-terminus tagged locus115098, the localization is mostly cytoplasmic 
with a much diffused pattern. Arrows in panel B’ indicate cells in mitosis and unlike 
non-dividing cells, Loc115098 is observed in the nucleus. (See Figure 3.7) 
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Figure3.7. Plasmids carrying N-terminus flag-epitope tagged Loc115098 were 
transfected to MCF-7 human mammary cells. Nuclear structures were monitored by 
epifluorescence microscopy using DNA intercalating Hoescht-33258 (Sigma) blue 
fluorescing dye (Panels A, B). Transfected cells were analyzed by 
immunofluorescence by using texas-red (red fluorescing dye) labelled flag-specific 
antibodies (Panels A’ and B’). 
 
3.3.3. Localization studies with anti-Loc115098  
Another construct was prepared by inserting loc115098 with BamHI and HindIII into 
a plasmid called pcDNA3.1/myc-His C (Invitrogen) and we made further localization 
analyses but this time with anti-Loc115098 antibody which was designed for the first 
24 amino acids in the whole sequence. In this study our results indicated that 
Loc115098 is almost always cytoplasmic and even though there were cells going 
through mitosis, the localization was persistent and we never observed it in the 
nucleus. Instead in the cells which were going through mitosis the localization was 
around the nucleus. Interestingly enough, the staining of Loc115098 was observed in 
the centrioles as well. This data does not support the previous one, however it is 
likely to be more reliable because the staining was carried out by an antibody 
specific to Loc115098 itself. (See Figure 3.8)  
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Figure3.8 Plasmid carrying Loc115098 was transfected to MCF-7 human mammary 
cells. Nuclear structures were monitored by epifluorescence microscopy using DNA 
intercalating Hoescht-33258 (Sigma) blue fluorescing dye (Panel A). Transfected 
cells were analyzed by immunofluorescence by using texas-red (red fluorescing dye) 
labelled Loc115098-specific antibody (Panel A’). 
3.4. Aspergillus nidulans Expression Data 
3.4.1. Human and Aspergillus protein alignment confirms the conservation 
After we observed the localization of Loc115098 in the nucleus we set new goals for 
our project. Since A. nidulans is an easily handled organisms we decided to carry on 
our studies with this lower eukaryote to better understand the function of Loc115098 
in cells. Firstly the conservation between these two proteins was checked and 34.4% 
identity was discovered, indicating a good conservation. (See Figure 3.9) 
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Figure3.9 The human Loc115098 was aligned with its homologue in A.nidulans by a 
commonly used alignment tool ClustalW. Here we observe the high conservation 
between these two organisms. 
3.4.2. Different strains of Aspergillus nidulans indicate different expression 
patterns 
Several A.nidulans strains were used in this study. These strains had different growth 
requirements and expression levels.  
3.4.2.1. The growth difference between the wild type and cell cycle mutant strains 
The wild-type strains grow normally at 37ºC whereas the cell cycle mutant strains 
have restrictive and permissive temperatures. At their permissive temperatures they 
grow normally, however when they are grown at restrictive temperatures the cell 
cycle gets arrested at different stages depending on the strain. Before starting our 
studies we wanted to confirm this data. 
 
 
 
Aspergillus  MGGKKGGGEN SKKAAGNARK AEAAANKKAI EDQKRAAEED KQWAKGA.KS 
Human  .MPKKFQGEN TKSAAARARR AEAKAAADAK KQKELEDAYW KDDDKHVMRK 
Consensus  .ggKKgqGEN sKkAAarARr AEAaAaadAi e#qeraaaed K#daKga.rk 
                      
Aspergillus  SSKKEEAEAK KAEAARKKAE RDALLAAEEA SQPS..KPKN NKSAAKKNAP 
Human  EQRKEEKEKR RLDQLERKKE TQRLLEEEDS KLKGGKAPRV ATSSKVTRAQ 
Consensus  eqrKEEaEar ra#aarrKaE r#aLLaaE#a kqkg..aPrn akSaakkrAq 
                   
Aspergillus  SRGTLNLD.Q LDDAPSSRAS A......... ..LNASGIDN AL.......D 
Human  IEDTLRRDHQ LREAPDTAEK AKSHLEVPLE ENVNRRVLEE GSVEARTIED 
Consensus  irdTLrrD.Q Lr#APdsaak A......... ..lNargi## al.......D 
                   
Aspergillus  ALSLTSKDTS KVDRHPERRY KAAYAAFEAR RLPEIEAENP GLRRQQRIEL 
Human  AIAVLSVAEE AADRHPERRM RAAFTAFEEA QLPRLKQENP NMRLSQLKQL 
Consensus  AiallSkaee aaDRHPERRm rAA%aAFEaa rLPrieaENP n$RrqQri#L 
                                                  
       Aspergillus  VKKEFDKSPE NPFNQVHVAF DASKEEIAAV REAERKKTEA RLTR 
             Human  LKKEWLRSPD NPMNQRAVPF NAPK...... .......... .... 
         Consensus  lKKEfdrSP# NPmNQraVaF #ApK...... .......... .... 
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Figure3.10. All the A.nidulans strains were grown on complete media. The bimE7 
and NimA5 strains grow normally at 30ºC and are not viable at 42ºC which is their 
restrictive temperature. The sudD7 grows normally at 37º and very poorly at 25ºC. 
(WT: wild-type)   
3.4.2.2. The Northern Blot Assays confirm the different expression pattern at 
different temperatures 
After observing the growth difference of several different strains at various 
temperatures, the AN0879.3 expression was further analyzed. In order to understand 
its expression pattern, the Northern blot analyses were performed (see Figure 3.11A). 
Before the hybridization, the methylene blue staining was performed in order to 
confirm the equal loading of the samples (see Figure 3.11B). The AN0879.3 probe 
was utilized in order to hybridize the isolated RNAs. While preparing the probe, the 
ORF (open reading frame) of the gene was taken into consideration. Our results 
consistently indicate that the cell cycle mutant strains have a higher expression 
profile at their restrictive temperatures. The restrictive temperatures of these strains 
represent a mitotic arrest at different stages of the cell cycle. This result has also been 
confirmed by densitometric analyses of the bands (See Table 3.1). In this analysis, 
firstly the density of the bands corresponding to each strain was measured by using 
the software Dolphin-1D, Wealtec Corp.,  and in the table it is represented as ‘Raw 
Data’. The ratio of each strain in its permissive and restrictive temperature was 
bimE7
25ºC 30ºC 37ºC 42ºC
sudD7
WT
nimA5
25ºC 30ºC 37ºC 42ºC
WT paba¯
WT argB¯
WT pyrG¯
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indicated as 'Fold Change.’ For the measurement of equal loading, the rRNAs were 
stained by methylene blue; with the same method the density of each band 
corresponding to the 18S rRNA was measured. Later the 'Fold Change' was corrected 
by finding the fold difference between the density of the Northern Blot bands and 
18S rRNA bands. This was called 'Corrected Fold Change.' Together with the 
densitometric analyses it is very likely that the AN0879.3 expression increases 
depending on the cell cycle arrest at various stages whereas in the wild type strain the 
corrected fold difference is less than one. In other words, when the cells are arrested 
at different cell cycle stages depending on the mutations they carry the AN0879.3 
expression increases accordingly.  
 
 
 
 
Figure3.11. In this Northern blot analysis RNA isolated from different A. nidulans 
strains are probed by AN0879.3 and their expression profiles are compared. A: 
Probed samples are indicated. B: Methylene Blue Staining was done for the 
confirmation of equal loading. The expression profile of the cell cycle mutants differ 
dramatically upon change of temperature when compared to wild-type strain. It is 
speculated that mitotic arrest causes this overexpression of AN0879.3, indicating a 
possible link between this protein and the process of mitosis. 
Table 3.1 The densitometric analyses of Northern Blot results. 
Strains Raw Data Fold Change Corrected Fold Change
WT 25 24,875
WT37 13,397
BimP 35,464
BimR 47,717
SudDP 46,335
SudDR 64,436
SudD,bim?P 26,207
SudD,bim?R 52,841
NimP 0,352
NimR 10.102 28698,86364
0,439132729
1,139749686
1,145929928
1,262465523
13205,4811
0,538572864
1,345505301
1,390655012
2,016293357
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3.5. Subcellular Localization of AN0879.3 in Aspergillus nidulans mycelia 
Our next goal was to analyze the subcellular localization of AN0879.3 in A.nidulans 
strains. For this purpose we used NimA5, BimE7, SudD7 and wild type control 
strains, the cell cycle mutants were specifically important for the study because a 
change in the localization of AN0879.3 during different stages of cell cycle could 
have been very important and crucial for our studies because our hypothesis was that 
AN0879.3 was somehow involved in mitosis. On the other hand this would be a 
good control of our previous localization studies as we would be able to compare the 
subcellular localization of the protein in lower and higher eukaryotes.  
3.5.1. The subcellular localization of AN0879.3 in several strains of A. nidulans  
For this experiment, the plasmid which was planned to be used in this study was 
constructed firstly by inserting a AN0879.3 fragment with BamHI and HindIII poly 
linkers into pBSK which was already digested with the same enzymes. Later the stop 
codon of AN0879.3 was destroyed and an NcoI site was inserted into the sequence as 
described in the methods. The GFP sequence was amplified and inserted into this 
plasmid with an NcoI linker. Eventually we obtained the plasmid called pLOCGFP 
which carried GFP in the C-terminus of AN0879.3. This plasmid was transformed 
into each strain by the method which is explained in detail in the methods section. 
Following the transformation, the strains were grown on CM in Petri dishes and they 
were checked whether or not they were carrying our gene of interest together with 
GFP. Later the copy number of these transformants was detected by Southern Blot 
analyses and the ones carrying single and multi copy were further studied. The 
results were the same for both and they were both promising. (See Figure 3.15) 
For microscopic analyses the conidiospores were inoculated in MM growing on 
poly-L-lysine coated cover slips. When they were forming mycelia the growth was 
terminated and the cover slips were removed from the Petri dishes to perform 
fixation and further staining. The results we obtained from epifluorescent studies 
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indicated that AN0879.3 was almost always cytoplasmic independently of the cell 
cycle regulation. It was mostly located in the cytoplasm however rarely observed 
around the nucleus of cell cycle arrested cells. There was an obvious change in the 
localization characteristics of Loc115098 in two different organisms and possible 
reasons causing this outcome will be discussed in the discussion part. 
 
 
 
 
 
 
 
 
 
Figure3.12. The pLOCGFP transformed strains are grown in minimal media and on 
cover slips. The pictures which were taken by epifluorescent microscope indicate the 
cytoplasmic localization of AN0879.3. The temperatures are the restrictive 
temperatures of the mutants and 25ºC is the optimal condition for GFP observation in 
wild-type strains. 
3.6. Overexpression Studies in Aspergillus nidulans 
We also aimed to check the possible effects of AN0879.3 overexpression in wild-
type strains. For this purpose we constructed a plasmid in which the AN0879.3 was 
under a controllable alcA (alcohol dehydrogenase) promoter. This method was 
designed according to Felenbok et al., 2001 (Felenbok et al., 2001).  Upon the 
addition of ethanol in the medium, the alcA promoter gets activated and the 
AN0879.3 expression increases whereas the presence of glucose in the medium 
represses the promoter and the AN0879.3 expression is turned down. Thus, our aim 
was to observe any phenotypical changes due to overexpression of AN0879.3. 
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3.6.1. The outcomes of overexpression of AN0879.3  
Firstly we designed a construct to transform the strains. The pALC plasmid was 
kindly provided by Dr V. Sophianopoulou’s group. After all the cloning steps this 
plasmid was named pALCLOC (see Figure 3.13). This plasmid was transformed into 
each strain by the method which is explained in detail in the methods section. 
Following the transformation the transformants were grown on CM in Petri dishes 
and they were checked whether or not they were carrying our gene of interest 
together with alcA promoter in the correct orientation by PCR. The correct 
orientation meant that the AN0879.3 was intact with the promoter, confirming that it 
is under the control of this promoter. Later the copy number of these transformants 
was detected by Southern Blot analyses and the ones carrying multi copy were 
further studied. The results represent the multi copy transformants. We chose the 
multi copy transformants on purpose because our aim was to observe the possible 
outcomes of the overexpression of AN0879.3. Thus the more copy numbers meant 
more expression. 
 
  
 
 
 
 
Figure3.13. The confirmation of pALCLOC construct. In figure A, the 1337bp long 
fragment represents the insert. The uncut plasmid is loaded into the gel together with 
the digested plasmid. In figure B, the plasmid containing 1600bp long argB selection 
gene is digested by EcoRI indicates the insert. An empty vector which is digested 
with the same enzyme is present as a control. 
There were two wild-type strains which were used for this study; their genetic 
background was as following: pyrG89, paba, panto and pyrG89, argB, paba, panto. 
Following the transformation and isolation of pyrG89-positive and argB-positive 
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transformants, the growth tests were carried out in order to see the possible effects of 
overexpressed AN0879.3 in these strains. The overexpression results indicated no 
phenotypic change of these strains. The possible reasons and future perspectives 
about this result will further be discussed in the discussion part. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.3.14. The wild-type, pyrG89, paba, panto and wild-type argB, pyrG89, paba, 
panto strains were transformed with pALCLOC plasmid and the transformants were 
confirmed by Southern blot analyses. The growth tests were performed in order to 
observe the possible outcomes of AN0879.3 overexpression. No dramatic phenotype 
change was observed according to the growth tests. (Growth tests were conducted in 
the same petri dish).  
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We also conducted some experiments to measure the growth rate of these strains 
together with a wild-type control. We initiated the experiment with the same conidia 
number for each strain by counting the conidia in the heamocytometer. After that, 
every 2 hours we checked the conidia number under the microscope for each strain. 
This has not revealed a significant growth rate difference between the AN0879.3 
overexpressing strains and the strains carrying a single copy of AN0879.3.  
3.7. Knock-out Studies of AN0879.3 
One of the most important goals for this project, and the main reason why A. 
nidulans was used as a model system in this study, was the generation and 
characterization of mutants lacking functional AN0879.3. A sophisticated method 
called double-joint PCR was initially utilized for the preparation of linear AN0879.3 
knock out construct. Later on, a cloning strategy was followed in order to make the 
constructs necessary for the investigation of strains where AN0879.3 is conditionally 
knocked-out. 
3.7.1. Strategy for the knock-out construct by Double-Joint PCR 
The technique was adapted from Jae-Hyuk Yu et al., 2004 (Yu et al., 2004). It is 
schematically explained in the Figure 3.15. In order to knock out the AN0879.3, 
Firstly, different primers (A, B, C, D, X, Y) were designed to amplify the 5’ 
AN0879.3, 3’ AN0879.3 and pyr4 gene separately. This 1st round PCR was 
performed according to the protocol which was as follows: 1xPhusion HF buffer, 
200µM of each dNTP, 0,5µM of each primer, 1U of Phusion High-Fidelity DNA 
Polymerase (Finnzymes), the reaction was performed in 50µl (98ºC 30seconds, 35 
cycles of [98ºC 15 seconds, 54ºC 30seconds, 72ºC 2,5 minutes] and 72ºC 10 
minutes). In this case the pyr4 is the selection gene which was obtained from 
Neurospora crassa genome. It is selected for the complementation of pryG89; these 
two genes have different DNA sequences however the proteins are capable of 
complementing each other. Some of these primers (C, D, X, Y) had flanking 
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sequences which are shown in different colors in the figure. Once these three 
fragments were obtained separately, a new PCR amplification which we called 2nd 
round PCR was set to obtain the knock out construct that bears 5’ AN0879.3, 3’ 
AN0879.3 and pyr4 gene. In this second round PCR, the flanking regions of the 
previously amplified fragments served as primers which maintained the annealing of 
these 3 fragments and following the annealing step the amplification was carried out 
in the same reaction with the primers called CPF5Fo shown as A and CPF3Re shown 
as B in the schematic explanation. The condition for this reaction was as following: 
1xEXT buffer, 360µM of each dNTP, 1µM of each primer, 3 U of DyDNAzyme 
EXT DNA Polymerase (Finnzymes), the reaction was performed in 50µl (4 minutes 
at 94ºC, 9 cycles of [30 seconds 94ºC, 30 seconds at 54ºC, 6 minutes and 40 seconds 
at 70ºC], 19 cycles of [30 seconds at 94ºC, 30 seconds at 54ºC, 6 minutes and 40 
seconds at  70ºC -in every cycle 20 seconds were added onto the extension time], 10 
minutes at 70ºC). The final product was gel extracted by using the Qiagen gel 
extraction kit and this fragment was confirmed by several restriction enzyme 
digestions. (See Figures 3.15 and 3.16) 
 
 
 
 
 
 
 
Figure3.15. The rationale of the Double-Joint PCR is explained in a schematic 
manner. The primers A and C were used to amplify 5’ end of AN0879.3, the primers 
called B and D were used to amplify 3’ AN0879.3 and the primers called X and Y 
were used to amplify pyr4 gene. The C, D, X and Y had flanking regions to serve as 
primers for the 2nd round PCR. (ORF: Open Reading Frame) 
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Figure3.16. In the first round PCR, 3 fragments were amplified separately, in the 
second round these 3 fragments were annealed and amplified with the primers called 
A and B. The final product was pointed with an arrow in the figure. 
Later this construct was utilized to transform A.nidulans strains. After the 
transformation, the construct we introduced created a knock-out allele through the 
homologues recombination at the 5’ AN0879.3, 3’ AN0879.3. Our preliminary data 
has indicated that this gene is essential for life because we haven’t observed any 
living cells carrying the knock out construct so far. All the transformants we obtained 
were checked for the existence of the inserted construct which in all cases was found 
to be ectopic.   
The primers called ‘5∆McaP Fo’, ‘5 ∆McaP Re’, ‘3 ∆McaP Fo’, ‘3 ∆McaP Re’ were 
specially designed to check the existence of the inserted construct. The primer called 
‘5∆McaP Fo’ was designed 357bp upstream of the 5’flanking start region and the 
‘5∆McaP Re’ was designed in the 717bp downstream of 5’ flanking end region. The 
‘3∆McaP Fo’ primer was 222bp upstream of the 3’flanking start region and the 
‘3∆McaP Re’ primer was 334bp downstream of the 3’flanking end region. The 
rationale was to observe the amplification of this fragment in case the linear 
∆AN0879.3 was integrated in the genome. Such amplification was never achieved 
(data not shown) and it proved us that knocking out the AN0879.3 from the A. 
nidulans genome is likely to cause lethality.  
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3.7.2. A new strategy to conditionally knock out the AN0879.3 
Our new strategy was to develop a new technique to be able to conditionally knock 
out AN0879.3. For this reason we decided to prepare a knock-in where by 
homologous recombination, the AN0879.3 promoter will be replaced by the alcA 
promoter (see Figure 3.17). This way we can isolate a transformant where AN0879.3 
expression is under the control of an inducible promoter, allowing us to turn it on and 
off just by manipulating the growth medium. For instance, initially different strains 
can be grown and at different stages during development the gene can be turned off 
and the morphology, growth rates or nuclear conditions can be investigated, 
moreover this experiment can be compared with the cell cycle mutants.  
For this reason we designed new oligos and we continued our work by cloning these 
fragments into pBKS. Firstly the 5’ flanking region of AN0879.3 was amplified by 
5’ FOR KpnI and 5’ REV EcoRI and cloned into pBKS which was double digested 
with the same enzymes. After the ligation and transformation into E. coli the plasmid 
called p5’LOC was obtained. Later this plasmid was digested by EcoRI and XbaI and 
the pyr4-3’ AN0879.3 fragment was amplified with the primers called “Pyr4 FOR 
EcoRI” and “3’ REV XbaI” and inserted into this plasmid. After that p∆LOC 
plasmid was obtained. Later the primers called ‘ALCMcaP For+’ and ALCMcaP 
Rev+ were utilized to amplify the AlcLOC fragment from the pALCLOC which we 
prepared earlier. And later both this fragment and the p∆LOC were digested with 
EcoRI and they were ligated to obtain pCONKO, there were two correct plasmids 
which were named as 1 and 13. Afterwards with these plasmids several different 
restriction enzyme digestions were performed to confirm the orientation of the 5’ 
AN0879.3-AlcA-AN0879.3-Pyr4-3’ AN0879.3 fragment in the plasmid. The results 
we obtained from the HindIII, EcoRI and SmaI enzymes not surprisingly proved us 
that both plasmids gave the same restriction pattern. Later when we digested them 
with SalI we observed that these two plasmids had different orientations.  
According to our cloning strategy we knew exactly where these enzymes had their 
recognition sites therefore we named the number 1 as pCONKO(+) and the number 
13 was named as pCONKO(-). The rationale to keep both of these plasmids 
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was to utilize them both for further studies, because after the transformation of the 
linear fragments into A.nidulans, it causes homologues recombination through the 
recognition sites. For the (+) oriented plasmid pCONKO(+), there were two 
possibilities of homologues recombination, it would either occur through the flanking 
region recognition sites or each site together with AlcA promoter meaning that it 
would give rise to unwanted integrations and unwanted knock-out sequences. 
However, the second possibility was not very likely to occur due to the size of the 
flanking regions which were big enough to provide appropriate conditions for the 
homologous recombination to occur, we still decided to keep the (-) oriented plasmid 
pCONKO (-) which had a higher possibility of the desired recombination to occur. 
The desired recombination occurs when the long flanking regions are used to give 
rise to homologues recombination. 
After obtaining these two plasmids, both were double digested by KpnI and XbaI to 
obtain the linear fragment which was ready to be transformed into A. nidulans. The 
transformation was performed once and the preliminary results indicate that when the 
AN0879.3 expression is allowed in the medium containing ethanol there was no 
obvious phenotypic change and the transformants grew normally whereas when the 
AN0879.3 expression was not allowed by growing the transformants in the glucose 
containing medium the growth was obviously affected in comparison with the 
internal control. 
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Figure3.17. The 2 pCONKO plasmids which were obtained after our cloning 
procedure were further analyzed by several restriction enzyme digestions and the 
different orientations were confirmed. These 2 plasmids were both utilized for the 
transformation experiments separately. 
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4. DISCUSSION 
AN0879.3 is a newly identified gene by our group. The bioinformatics analyses 
revealed very interesting results about the features of this gene. The high 
conservation rate indicates that this is rather an important gene which is conserved 
during evolution. Therefore any attempt to functionally characterize the gene should 
be considered as a very crucial step and needs to be taken into consideration with 
special rigour. However prior to the initiation of the project we were aware of some 
certain difficulties. Firstly the gene of interest does not fall into any category with the 
previously known genes. Thus it was considered to be a ‘hypothetical protein’ and 
this obliged us to firstly confirm that the transcript of the gene exists in different 
tissues and organisms.  
We could have initiated our study from totally a different point of view. As it is 
explained in the scientific work which was carried out by Eisenstein et al., 2000 the 
structural approach could have been the best and the most reliable way to study this 
new protein. In the paper the importance of studying the structure of a given 
hypothetical protein is clearly explained and suggested as a promising method. 
However there are certain difficulties of following this suggested method such as the 
bottlenecks of crystallization, X-ray diffraction and NMR (Nuclear Magnetic 
Resonance) spectroscopy. All of these techniques require specialization and very 
sophisticated equipments. Thus we started our study from a more biochemical point 
of view. 
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4.1. The subcellular localization studies 
Our localization studies have indicated that in MCF-7 human mammary gland cell 
lines the localization of Loc115098 is mostly cytoplasmic but also in the nucleus in 
mitosis whereas in A. nidulans the localization of AN0879.3 was always observed in 
cytoplasm and never in nucleus. This was a very consistent result. There might be 
several explanations to this result.  
Firstly in human cell line MCF-7 we performed our experiments by tagging 
Loc115098 either with N-terminus FLAG epitope or C-teminus FLAG epitope. In 
A.nidulans studies the AN0879.3 was tagged with GFP only in the C-terminus of the 
protein. We suspect that the more charged amino acid composition of the C terminus 
of Loc115098 may play an important role in directing the subcellular localization of 
this protein. However there is another evidence that the mitosis occurs differently in 
these two organisms. It is a well known fact that A. nidulans has a closed mitosis 
whereas in higher eukaryotes like humans the open mitosis occurs. As it is explained 
by S.Sazer (Sazer, 2005), the nuclear envelope never breaks down to reform itself 
again. In other words in higher eukaryotes the nuclear envelope disassociates during 
the mitosis whereas in lower eukaryotes it does not change structure (See Figure 4.1). 
This might be another explanation for the discrepancy of the result we obtained. 
After observing AN0879.3 never localizing in the nucleus in A. nidulans it is 
possible to speculate that AN0879.3 is a dynamic component of the nuclear envelope 
with a short turn over period. It is mostly observed in the cytoplasm although it 
should be taken into consideration that both the human and the A. nidulans copy of 
the gene carry nuclear localization signals predicted by in silico methods. Therefore 
we might expect to observe the localization of AN0879.3 in the nucleus.  
Our preliminary results from the experiments with anti-Loc115098 has indicated that 
even the cells are dividing Loc115098 is localized around the nucleus as if it is 
surrounding the nuclear material. This seems as a supporting data confirming the A. 
nidulans experiment results. However it is still elusive where exactly Loc115098 
protein localizes during mitosis. This preliminary data suggesting the perinuclear 
localization may be due to the different stages of mitosis. Because we conducted 
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no synchronization experiment we are unable observe the different stages of mitosis 
in one go. Therefore it is possible to speculate that in dividing cells the localization 
of Loc115098 might alter due to different mitotic stages. In other words we can 
speculate that the localization of Loc115098 differs while the cells proceed into 
mitosis. For instance it might be speculated that while cells are going through 
anaphase and telophase it is observed as a surrounding matter around the nucleus 
whereas during metaphase it is located in the nucleus. Even though there is still some 
uncertainty it is likely to be a component of the nuclear envelope. However further 
investigations should be done concerning the possible interactions between the 
Loc115098 and other proteins.  
Another observation coming from anti-Loc115098 staining is that, this protein also 
localizes in the centrioles. Thus centriole staining together with Loc115098 might be 
a good approach to better understand this issue. As well as centriole staining another 
good approach might be to stain microtubules to distinguish the localization of 
different cell components during mitosis. 
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Figure4.1 The schematic explanation of the mitosis in higher and lower eukaryotes. 
The higher eukaryotes have open mitosis whereas the lower eukaryotes go through 
closed mitosis. 
Considering where Loc115098 is localized in the cell, there is another interesting 
study carried out by Thisse et al, 2004 (Thisse et al., 2004). In this study they 
performed a high throughput localization screen of some expressed genes in the 
pectoral fin stage of the development by in-situ hybridization. Their results indicated 
that Loc115098 has rather a diffused localization in the embryos meaning that it 
localizes in the nucleus as well as the cytoplasm.  (see Figure 4.2) 
 
 
Figure4.2. The in-situ hybridization to identify Loc115098 localization in the 
zebrafish embryos. All embryos are in pectoral fin stage during the development. 
The stained regions represent the embryos and unstained regions are the yolks. 
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4.2. The overexpression study 
Our overexpression study in A.nidulans aimed to observe any phenotypical changes 
due to the overexpression of AN0879.3 in the cell. In our results we have not 
observed such a phenotypic change. There might again be several explanations for 
this outcome. Firstly the repressible AlcA promoter might have a higher background 
than it is thought to have and the expression level might not be as strong as it was 
expected to be. However this is probably not the case because in some studies it is 
accepted to be one of the most reliable controllable promoters (Pachlinger et al., 
2005). The overexpression of AN0879.3 caused no phenotypical change most 
probably due to a possible tolerance mechanism in the cell. It might be assumed that 
only a certain amount of AN0879.3 is needed in the cell and therefore the excess is 
not utilized by the cell. Concerning the experiment we have a serious drawback 
because no Northern Blot analyses have been performed in our experiments to check 
the expression levels. Instead we assumed that strains carrying multiple copies of 
Alc-AN0879.3 were overexpressing the protein. More experiments should be 
performed to further analyze and confirm this result.  
4.3. The knock-out studies 
Our results have indicated that knocking out AN0879.3 from the genome is very 
likely to cause lethality in the organism. In other words it proves that AN0879.3 is a 
very crucial gene for the survival of the organism. We firstly designed a linear 
construct according to Yu et al., 2004 to replace the ORF of the gene with the marker 
gene pyr4. Theoretically, after the transformation of A. nidulans with this causes a 
homologous recombination event which eventually gives rise to a knock-out strain. 
We obtained and checked several transformants by PCR with specially designed 
oligos however we never came across a true knock-out strain. After that we aimed to 
confirm this through another system which we generated and called ‘Conditional 
Knock-Out Strategy’. Even though this effort is currently in progress, we are 
confident that the knock-out of the gene of interest causes lethality. Therefore both 
the results and the conditional knock-out aim are crucial for this study.  
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4.4. Future perspectives 
Concerning Loc115098, there are still plenty of questions to be answered. The 
immediate goal of this project is to carry out a knock-out study in human mammary 
gland cell line MCF7 by using RNAi methodology. The aim in this study is to 
silence the loc115098 gene in the genome by designing 21 nucleotide long oligos and 
observe the obvious changes in MCF7 cell line. This is an ongoing project and the 
results from this study will reveal new perspectives and will bring new insights to the 
project.  
In addition to that we have already designed an anti-Loc115098 antibody and 
confirmed that it is working properly by testing it with Western Blot assays. Since 
we have the anti-Loc115098 antibody we are currently aiming to perform 
immunoprecipication experiments to find out the putative Loc115098 interacting 
proteins in the cells. Moreover the expression of Loc115098 is also being checked by 
immunohisto chemistry to further confirm the in situ labeling of the gene in different 
mouse tissues. 
As mentioned before there are a lot of questions remained to be addressed in order to 
learn and understand the function of Loc115098 more. Therefore all different 
approaches aiming to functionally characterize this new protein will indeed be 
valuable. We are confident that when the function and the pathways in which 
Loc115098 participates are revealed, this will answer at least some of the questions 
which still remain unanswered. Hopefully it will be an important scientific 
contribution to the understanding of certain metabolic events.
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